A KCNQ channel opener for experimental neonatal seizures and status epilepticus

Annals of Neurology

Volumn 65, Issue 3, 2009, Pages 326-336

  Raol, YogendraSinh H ^a   Lapides, David A ^b   Keating, Jeffery G ^b   Brooks Kayal, Amy R ^a,c   Cooper, Edward C ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; FLUPIRTINE MALEATE; FLUROTHYL; KAINIC ACID; PHENOBARBITAL; POTASSIUM CHANNEL KCNQ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCORTICOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; MALE; NEWBORN; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMINOPYRIDINES; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; FLUROTHYL; KAINIC ACID; KCNQ POTASSIUM CHANNELS; MALE; PHENOBARBITAL; PREGNANCY; RATS; SEIZURES; SPECTRUM ANALYSIS; STATUS EPILEPTICUS; TIME FACTORS;

EID: 65249140516     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21593     Document Type: Article

References (55)

1. Silverstein FS, Jensen FE. Neonatal seizures. Ann Neurol 2007; 62:112-120.
2. Pisani F, Cerminara C, Fusco C, Sisti L. Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology 2007;69:2177-2185.
3. Ronen GM, Buckley D, Penney S, Streiner DL. Long-term prognosis in children with neonatal seizures: a population-based study. Neurology 2007;69:1816-1822.
4. Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999;341:485-489.
5. Olney JW, Young C, Wozniak DF, et al. Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci 2004;25:135-139.
6. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089-15094.
7. Sankar R, Painter MJ. Neonatal seizures: after all these years we still love what doesn't work. Neurology 2005;64:776-777.
8. Silverstein FS, Jensen FE, Inder T, et al. Improving the treatment of neonatal seizures: National Institute of Neurological Disorders and Stroke workshop report. J Pediatr 2008;153: 12-15.
9. Cooper EC, Jan LY. M-channels: neurological diseases, neuromodulation, and drug development. Arch Neurol 2003;60: 494-500.
10. Schroeder BC, Kubisch C, Stein V, Jentsch TJ. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K channels causes epilepsy. Nature 1998;396:687-690.
11. Singh NA, Westenskow P, Charlier C, et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003;126:2726-2737.
12. Steinlein OK, Conrad C, Weidner B. Benign familial neonatal convulsions: always benign? Epilepsy Res 2007;73:245-249.
13. Okada M, Zhu G, Hirose S, et al. Age-dependent modulation of hippocampal excitability by KCNQ-channels. Epilepsy Res 2003;53:81-94.
14. Devaux JJ, Kleopa KA, Cooper EC, Scherer SS. KCNQ2 is a nodal K+ channel. J Neurosci 2004;24:1236-1244.
15. Pena F, Alavez-Perez N. Epileptiform activity induced by pharmacologic reduction of M-current in the developing hippocampus in vitro. Epilepsia 2006;47:47-54.
16. Peters HC, Hu H, Pongs O, et al. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 2005; 8:51-60.
17. Schwarz JR, Glassmeier G, Cooper EC, et al. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier. J Physiol 2006;573:17-34.
18. Pan Z, Kao T, Horvath Z, et al. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci 2006;26:2599-2613.
19. Rasmussen HB, Frokjaer-Jensen C, Jensen CS, et al. Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment. J Cell Sci 2007;120: 953-963.
20. Peretz A, Degani N, Nachman R, et al. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol 2005;67:1053-1066.
21. Porter RJ, Partiot A, Sachdeo R, et al. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 2007;68:1197-1204.
22. Martire M, Castaldo P, D'Amico M, et al. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J Neurosci 2004;24:592-597.
23. Wickenden AD, Krajewski JL, London B, et al. N-(6-chloropyridin-3-yl)-3, 4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Mol Pharmacol 2008;73:977-986.
24. Wickenden AD, Roeloffs R, McNaughton-Smith G, Rigdon GC. KCNQ potassium channels: drug targets for the treatment of epilepsy and pain. Exp Opin Ther Patents 2004;14: 2-13.
25. Wua YJ, Dworetzky SI. Recent developments on KCNQ potassium channel openers. Curr Med Chem 2005;12:453-460.
26. Dhar S, Bitting RL, Rylova SN, et al. Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons. Ann Neurol 2002;51: 448-466.
27. Seyfried J, Evert BO, Rundfeldt C, et al. Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells. Eur J Pharmacol 2000;400:155-166.
28. Otto M, Cepek L, Ratzka P, et al. Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology 2004;62:714-718.
29. Porter RJ, Gratz E, Narang PK, et al. Effect of flupirtine on uncontrolled partial or absence seizures. Epilepsia 1983;24: 253-254.
30. Jensen FE, Holmes GL, Lombroso CT, et al. Age-dependent changes in long-term seizure susceptibility and behavior after hypoxia in rats. Epilepsia 1992;33:971-980.
31. Hoffmann AF, Zhao Q, Holmes GL. Cognitive impairment following status epilepticus and recurrent seizures during early development: support for the "two-hit hypothesis." Epilepsy Behav 2004;5:873-877.
32. Raol YS, Budreck EC, Brooks-Kayal AR. Epilepsy after earlylife seizures can be independent of hippocampal injury. Ann Neurol 2003;53:503-511.
33. Good P. Permutation tests: a practical guide to resampling methods for testing hypotheses. New York: Springer, 2000.
34. Jensen FE, Baram TZ. Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility. Ment Retard Dev Disabil Res Rev 2000;6: 253-257.
35. Brunson KL, Schultz L, Baram TZ. The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation. Brain Res Dev Brain Res 1998;111:119-128.
36. Jensen FE, Blume H, Alvarado S, et al. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia. Epilepsia 1995;36:966-972.
37. McCabe BK, Silveira DC, Cilio MR, et al. Reduced neurogenesis after neonatal seizures. J Neurosci 2001;21:2094-2103.
38. Dzhala VI, Talos DM, Sdrulla DA, et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med 2005;11: 1205-1213.
39. Koh S, Jensen FE. Topiramate blocks perinatal hypoxiainduced seizures in rat pups. Ann Neurol 2001;50:366-372.
40. Maljevic S, Kempfle J, Weber YG, et al. Developmental expression of KCNQ2 and KCNQ3 potassium channels at the axon initial segments of the mouse brain. Society for Neuroscience Annual Meeting; 2007; San Diego, CA.
41. Cooper EC, Aldape KD, Abosch A, et al. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. Proc Natl Acad Sci USA 2000;97:4914-4919.
42. Geiger J, Weber YG, Landwehrmeyer B, et al. Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain. Neurosci Lett 2006;400:101-104.
43. Qiu C, Johnson BN, Tallent MK. K+ M-current regulates the transition to seizures in immature and adult hippocampus. Epilepsia 2007;48:2047-2058.
44. Otto JF, Kimball MM, Wilcox KS. Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Mol Pharmacol 2002;61:921-927.
45. Zimprich F, Ronen GM, Stogmann W, et al. Andreas Rett and benign familial neonatal convulsions revisited. Neurology 2006; 67:864-866.
46. Leppert M, Anderson VE, Quattlebaum T, et al. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989;337:647-648.
47. Lewis TB, Leach RJ, Ward K, et al. Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am J Hum Genet 1993;53:670-675.
48. Jentsch TJ. Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 2000;1:21-30.
49. Cooper EC, Harrington E, Jan YN, Jan LY M-channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J Neurosci 2001;21:9529-9540.
50. Xiong Q, Gao Z, Wang W, Li M. Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds. Trends Pharmacol Sci 2008;29:99-107.
51. Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 2005;6:850-862.
52. Schenzer A, Friedrich T, Pusch M, et al. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J Neurosci 2005;25:5051-5060.
53. Brooks-Kayal AR, Shumate MD, Jin H, et al. gamma- Aminobutyric acid(A) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J Neurochem 2001;77:1266-1278.
54. Dzhala VI, Brumback AC, Staley KJ. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 2008;63:222-235.
55. Glier C, Dzietko M, Bittigau P, et al. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004;187:403-409.